Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study

Prostate Cancer and Prostatic Diseases, Published online: 02 March 2020; doi:10.1038/s41391-020-0220-8Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study

Source: Prostate Cancer and Prostatic Diseases - March 1, 2020 Category: Urology & Nephrology Authors: Kerri Beckmann Hans Garmo Bertil Lindahl Lars Holmberg P är Stattin Jan Adolfsson J. Kennedy Cruickshank Mieke Van Hemelrijck Source Type: research